Literature DB >> 7070873

A quantitative model for hyaline membrane disease.

J Rojas, R S Green, L Fannon, T Olssen, D P Lindstrom, M T Stahlman, R B Cotton.   

Abstract

A model based on the course of 31 infants with uncomplicated hyaline membrane disease is described. Based on data collected over the first 12 hr of life, it predicts the course of an infant for the next 60 hr, and estimates the outcome in terms of length of oxygen requirement and assisted ventilation. For the construction of the model, right-to-left intra- and extra-pulmonary shunting, expressed as venous admixture, was considered as the principal mechanism of hypoxemia in hyaline membrane disease and mean applied proximal airway pressure was used to quantify management. The model provides an objective estimate of severity early in the course of disease, uses variables routinely available in an intensive care unit, and its use would strengthen the interpretation of clinical studies in which the comparability of experimental and control groups is critical.

Entities:  

Mesh:

Year:  1982        PMID: 7070873     DOI: 10.1203/00006450-198201001-00007

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  4 in total

1.  Predicting death from initial disease severity in very low birthweight infants: a method for comparing the performance of neonatal units.

Authors:  W Tarnow-Mordi; S Ogston; A R Wilkinson; E Reid; J Gregory; M Saeed; R Wilkie
Journal:  BMJ       Date:  1990-06-23

2.  Mechanical ventilation of the newborn.

Authors:  W Tarnow-Mordi; A Wilkinson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-01

3.  Lack of association between barotrauma and air leak in hyaline membrane disease.

Authors:  W O Tarnow-Mordi; A Narang; A R Wilkinson
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

4.  Early or late parenteral nutrition for the sick preterm infant?

Authors:  K G Brownlee; E J Kelly; P C Ng; S C Kendall-Smith; P R Dear
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.